Streetbeat News

Revenues

EWU

The U.K. Nationwide House Price Index (HPI) for July increased by 0.3% month-over-month, surpassing the estimated 0.1% and the prior 0.2%.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 6:04 am

ING

ING Groep reported a decrease in Q2 EPS to €0.54 from €0.60 YoY and a slight decline in sales to €5.716B from €5.759B YoY.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 5:54 am

PHAR

Pharming Group projects 2024 revenues between $280M and $295M, reflecting 14% to 20% growth. The company plans to expand its patient base for Joenja® therapy, increase ex-U.S. revenues, complete clinical trials, and seek regulatory approvals in multiple regions. Operating costs will be managed without significant cash burn, and potential acquisitions are being considered.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 5:44 am

PHAR

Pharming (NASDAQ:PHAR) reported a Q2 EPS of $(0.002), down from $0.002 YoY, with sales of $74.10M, up from $54.90M YoY, marking a 34.97% increase.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 5:42 am

MT

ArcelorMittal (NYSE:MT) reported Q2 2024 earnings of $0.63 per share, missing the analyst estimate of $0.71. Sales were $16.249 billion, also below the $16.521 billion estimate. Both earnings and sales showed significant declines compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 5:38 am

TNK

Teekay Tankers (NYSE:TNK) reported Q2 2024 adjusted EPS of $3.11, beating the $3.04 estimate. Sales were $296.590M, surpassing the $209.579M estimate. However, both EPS and sales decreased compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 5:36 am

TK

Teekay (NYSE:TK) reported a 20% decrease in Q2 EPS to $0.36 and a 17.52% decrease in sales to $326.14 million compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 5:34 am

BUD

Anheuser-Busch InBev (BUD) expects its 2024 EBITDA to grow in line with its medium-term outlook of 4%-8%. The company also anticipates capital expenditure of $4B-$4.5B, net finance costs of $220M-$250M per quarter, and an effective tax rate of 27%-29%.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 5:29 am

BUD

Anheuser-Busch InBev reported a 0.8% decline in total volumes for Q2, with own beer volumes down by 1.3% and non-beer volumes up by 3.4%.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 5:28 am

BUD

Anheuser-Busch InBev (NYSE:BUD) reported Q2 2024 earnings of $0.90 per share, beating the analyst estimate of $0.87. Sales were $15.333 billion, surpassing the $13.561 billion estimate. This represents a 25% increase in EPS and a 1.41% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 5:24 am